Abnova (Taiwan) Corporation (TPE:4133)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.10
+0.35 (1.26%)
Jul 25, 2025, 2:38 PM CST

Abnova (Taiwan) Company Description

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies.

The company’s products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations.

It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies.

In addition, the company provides integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services.

It serves academic, research institutions, and pharmaceutical factories. Abnova (Taiwan) Corporation was founded in 2002 and is headquartered in Taipei, Taiwan.

Abnova (Taiwan) Corporation
Abnova (Taiwan) logo
CountryTaiwan
Founded2002
IndustryBiotechnology
SectorHealthcare
CEOPeiru Ji

Contact Details

Address:
No. 108, Jhouzih Street
Taipei, 114
Taiwan
Phone886 2 8751 1888
Websiteabnova.com

Stock Details

Ticker Symbol4133
ExchangeTaiwan Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyTWD
ISIN NumberTW0004133004
SIC Code2836

Key Executives

NamePosition
Peiru JiGM and Director
Yaping ZhangAccounting Supervisor
Yi Huang HuangDeputy General Manager